This week, five Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
-
-
Sponsored By:
-
Sponsored By:
NVS
The 10 Biggest, Baddest ETFs on Wall Street
If you’re an investor with just a small nest egg looking to tap into the wealth of Wall Street, consider these 10 top ETFs as a place to start. More
7 Pharmaceutical Stocks to Buy Now
The grades of seven Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
Novartis Drug Shows Success With Plaque Psorasis
Novartis said that a new drug reduced moderate-to-severe symptoms in people suffering from plaque psoriasis nearly three times compared to a placebo in tests. More
Researchers Find Antibody That Might Help Prevent, Cure Flu
Researchers at Sea Lane Biotechnologies and Scripps Research Institute have discovered an antibody that stops the flu virus from attaching to healthy cells. More
FDA Approves Second Multiple Sclerosis Pill
The FDA has granted approval for Sanofi's multiple sclerosis drug, Aubagio, the second pill now available to treat the disease. More
Who Has the Best Pharma Pipeline?
A look through Big Pharma's drug pipelines shows a lot of promise across several companies, but one firm stands out as having big-time revenue growth potential. More
